The Prevalence of Helicobacter pylori Infection in Some Disease of the Esophagus, Stomach and Duodenum - A Retrospective Analysis;Prevalence infekce Helicobacter pylori u některých onemocnění jícnu, žaludku a dvanáctní ku - Retrospektivní analýza

Ceska a Slovenska Gastroenterologie a Hepatologie

Volumn 57, Issue 6, 2003, Pages 228-232

  Martinek J ^a   Hucl, T ^a   Spicak J ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

Duodenal ulcer; Helicobacter pylori; Prevalence; Reflux esophagitis; Stomach ulcer

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; DUODENUM DISEASE; DUODENUM ULCER; ESOPHAGUS DISEASE; ESOPHAGUS VARICES; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; PREVALENCE; REFLUX ESOPHAGITIS; STOMACH ADENOCARCINOMA; STOMACH BIOPSY; STOMACH DISEASE; STOMACH ULCER;

EID: 0142229413     PISSN: 1213323X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Martínek, J., Špičák, J., Pantoflíčková, D. Helicobacter pylori - co nového? Čes. a Slov. Gastroent., 2000, roč. 54, s. 24-34.
2. Kuipers, E. J., Thijs, J. C., Festen, H. P. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment. Pharmacol. Ther., 1995, roč. 9, Suppl. 2, s. 59-69.
3. Current European concepts in the management of Helicobacter pylori infection. The Maastricht consensus report. Gut, 1997, roč. 41, s. 8-13.
4. Malfertheiner, et al. Current concepts in the management of Helicobacter pylori infection - the Maastricht 2 2000, consensus report. Aliment. Pharmacol. Ther., 2002, roč. 16, s. 167-180.
5. El-Serag, H. B., Sonnenberg, A. Opposing time trends of peptic ulcer and reflux disease. Gut, 1998, roč. 43, s. 327-333.
6. Kopáčová, M., Bureš, J., Koupilová, I., et al. Prevalence of Hp infection in non-selected general population in Czech Republic. No birth-cohort phenomenon found in multicentre prospective study. Gut, 2002, roč. 51, Suppl. 3, s. A108.
7. Sugiyama, T., Nishikawa, K., Komatsu, Y., et al. Attributable risk of H. pylori in peptic ulcer disease: does declining prevalence of infection in general population explain increasing frequency of non-H. pylori ulcers? Dig. Dis. Sci., 2001, roč. 46, s. 307-310.
8. Ciociola, A. A., McSorley, D. J., Turner, K., et al. Helicobacter pylori infection rates in duodenal ulcer patients in the United States may be lower than previously estimated. Am. J. Gastroenterol., 1999, roč. 94, s. 1834-1840.
9. Blum, A. L., Talley, N. J., O'Morain, C., et al. OCAY Study Group. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N. Engl. J. Med., 1998, rom̌. 339, s. 1875-1881.
10. Koelz, H. R., Bolten, W., Dragosics, B., et al. Primary prophylaxis of NSAID-induced gastroduodenal ulcers and dyspepsia in H. pylori positive patients: Randomized, double-blind, placebo controlled treatment of Hp infection vs. omeprazole. Gastroenterology, 2000, rom̌. 118, s. A250.
11. Henry, A., Batey, R. G. Low prevalence of Helicobacter pylori in an Australian duodenal ulcer population: NSAI-Ditis or the effect of ten years of H. pylori treatment? Aust. N. Z. J. Med., 1998, rom̌. 28, s. 345.
12. McColl, K. E. Helicobacter pylori-negative ulcer disease. Dig. Liver Dis., 2000, rom̌. 32, s. 125-127.
13. Fixa, B., Komárková, O., Melichar, B., et al. Vyskyt infekce H. pylori u české dospělé populace. Čes. a Slov. Gastroent., 1995, rom̌. 49, s. 83-85.
14. Martínek, J., Hucl, T., Špičák, J. Diagnostika a léčba infekce H. pylori na přelomu milénia. Klin. mikrobiol. inf. lék., 2001, rom̌. 7, s. 58-65.
15. Martínek, J., Kužela, L., Špičák, J., Vavrečka, A. Review article: the clinical influence of Helicobacter pylori in effective acid suppression-implications for the treatment of gastro-oesophageal reflux disease. Aliment Pharmacol. Ther., 2000, rom̌. 14, s. 979-990.
16. Sacca, N., De Medici, A., Rodino, S., et al. Reflux esophagitis: a complication of Helicobacter pylori eradication therapy? Endoscopy, 1997, rom̌. 29, s. 224.
17. Mihara, M., Haruma, K., Kamada, T., et al. Low prevalence of H. pylori infection in patients with reflux esophagitis. Gut, 1996, rom̌. 39, Suppl. 2, s. A94.
18. Hackelsberger, A., Schultze, V., Gunther, T., et al. H. pylori prevalence in reflux esophagitis - a case control study. Gastroenterology, 1997, rom̌. 112, s. A137.
19. Labenz, J., Blum, A. L., Bayerdorffer, E., et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology, 1997, rom̌. 112, s. 1442-1447.
20. Vicari, J. J., Peek, R. M., Falk, G. W., et al. The seroprevalence of Cag-A positive H. pylori strains in the spectrum of gastro-esophageal reflux disease. Gastroenterology, 1998, rom̌. 115, s. 50-57.
21. Vaira, D., Holton, J., Menegatti, M., et al. Review article: invasive and non-invasive tests for Helicobacter pylori infection. Aliment. Pharmacol. Ther., 2000, rom̌. 14, Suppl. 3, s. 13-22.
22. Fixa, B., Komárková, O. Současné principy a způsoby léčby infekce H. pylori. Literární přehled a vlastní zkušenosti. Čes. a Slov. Gastroent., 1998, rom̌. 52, Suppl. 1, s. 3-14.
23. Malfertheiner, P., Veldhuyzen van Zanten, S., Dent, J., et al. Does cure of H. pylori infection induce heartburn? Gastroenterology, 1998, rom̌. 114, s. A212.
24. El-Serag, H. B., Sonnenberg, A., Jamal, M. M., et al. Corpus gastritis is protective against reflux oesophagitis. Gut, 1999, rom̌. 45, s. 181-185.
25. Fixa, B., Komárková, O., Nožička, Z. Dlouhodobé sledování nemocných s funkční žaludeční dyspepsií. Záyislost obtíží na přítomnosti infekce Helicobacter pylori. Čes. a Slov. Gastroent., 2001, rom̌. 55, Suppl. 1, s. 51.